Abstract
Uninterrupted warfarin with intra-procedural heparin is a commonly used anticoagulation strategy during atrial fibrillation (AF) ablation to decrease thromboembolic risk. We intended to study if novel oral anticoagulants (NOAC) had comparable efficacy and safety to that of warfarin for AF ablation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
